The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aldeyra Therapeutics Inc | COM | 01438T106 | 20,526,898 | 2,067,160 | SH | SOLE | 2,067,160 | 0 | 0 | ||
Altimmune Inc | COM NEW | 02155H200 | 733,706 | 173,864 | SH | SOLE | 173,864 | 0 | 0 | ||
Altria Group Inc | COM | 02209S103 | 1,012,874 | 22,700 | SH | SOLE | 22,700 | 0 | 0 | ||
Applied Therapeutics Inc | COM | 03828A101 | 2,797,950 | 3,450,000 | SH | SOLE | 3,459,000 | 0 | 0 | ||
Avadel Pharmaceuticals Plc | SPONSORED ADR | 05337M104 | 4,580,000 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
HOOKIPA PHARMA | COM | 43906K100 | 220,800 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
Verona Pharma | SPONSORED ADS | 925050106 | 4,016,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Biohaven Pharmactl Hldg Co L | COM | G11196105 | 6,152,764 | 450,422 | SH | SOLE | 450,422 | 0 | 0 | ||
Booz Allen Hamilton HLDG COR | CL A | 099502106 | 1,204,970 | 13,000 | SH | SOLE | 13,000 | 0 | 0 | ||
CVS Health Corp | COM | 126650100 | 1,077,495 | 14,500 | SH | SOLE | 14,500 | 0 | 0 | ||
Entera Bio Ltd | SHS | M40527109 | 2,881,759 | 2,484,275 | SH | SOLE | 2,484,275 | 0 | 0 | ||
Orgenesis, Inc. | COM | 68619K105 | 748,990 | 634,738 | SH | SOLE | 634,738 | 0 | 0 | ||
Ocular Therapeutix Inc. | COM | 67576A100 | 1,504,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Ocular Therapeutix Inc. | COM | 67576A100 | 504,866 | 95,800 | SH | Call | SOLE | 95,800 | 0 | 0 | |
Ocuphire Pharma Inc. | COM | 67577R102 | 375,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Omega Therapeutics Inc. | COM | 68217N105 | 1,043,250 | 173,010 | SH | SOLE | 173,010 | 0 | 0 | ||
Thermo Fischer Scientific Inc | COM | 883556102 | 1,213,800 | 2,100 | SH | SOLE | 2,100 | 0 | 0 | ||
Visa | COM CL A | 92826C839 | 1,093,481 | 4,850 | SH | SOLE | 4,850 | 0 | 0 | ||
SEABRIDGE GOLD INC | COM | 811916105 | 1,036,000 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
Silvercrest Metals Inc CAD | COM | 828363101 | 1,043,614 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
Global X Silver Miners ETF 37954Y848 | Global X Silver | 37954Y848 | 2,755,584 | 89,700 | SH | SOLE | 89,700 | 0 | 0 | ||
Vaneck Gold Miners ETF | Gold Miners ETF | 92189F106 | 2,971,347 | 91,850 | SH | SOLE | 91,850 | 0 | 0 | ||
Vaneck Junior Gold Miners ETF | Junior Hold Mine | 92189F791 | 2,099,425 | 53,150 | SH | SOLE | 53,150 | 0 | 0 | ||
OSISKO GOLD ROYALTIES LTD | COM | 68827L101 | 1,272,000 | 400,000 | SH | SOLE | 235,000 | 0 | 0 | ||
Franco Nev Corp CAD | COM | 351858105 | 1,020,600 | 7,000 | SH | SOLE | 7,000 | 0 | 0 | ||
Northrop Grumman Corp | COM | 666807102 | 999,623 | 2,165 | SH | SOLE | 2,165 | 0 | 0 |